Introduction
Primary effusion lymphoma (PEL) represents a peculiar lymphoma entity which consistently harbors infection by human herpesvirus type-8 (HHV-8, also known as Kaposi's sarcomaassociated herpesvirus (KSHV)). [1] [2] [3] [4] [5] At the clinico-pathological level, PEL is characterized by liquid growth in the serous body cavities and associates with spreading along the serous membranes without infiltrative or destructive growth patterns. 4, 6, 7 Although PEL usually displays an indeterminate (non B, non T) phenotype, immunogenotypic studies have unequivocally defined the B cell origin of this lymphoma. [1] [2] [3] [4] [5] The consistent association of PEL with HHV-8 infection of the tumor clone suggests that the virus is pathogenetically related to the disease. [1] [2] [3] [4] [5] [8] [9] [10] [11] [12] The pathogenetic role of HHV-8 is further supported by the observation that PEL cells express viral (v)-cyclin, a homolog of the cyclin D family which are positive regulators of cell cycle in human cells. [13] [14] [15] Although v-cyclin is thought to deregulate cell cycle control in PEL, it is currently unknown how v-cyclin expression correlates to that of negative regulators of cell cycle, such as the p27 Kip1 cell cycle inhibitor that modulates the cellular cyclins D. [16] [17] [18] Despite evidence supporting the role of HHV-8, the pathogenesis of PEL is not fully understood. Since PEL is represented in all cases by a monoclonal proliferation, it is conceivable that PEL development and growth also require the accumulation of molecular lesions of cellular cancer related loci. At present, karyotypic information in PEL is limited 19, 20 and several studies have defined that the neoplastic cells consistently lack most of the genetic lesions commonly seen in mature B cell malignancies.
Recently, it has been proposed that epigenetic inactivation of the DNA repair enzyme gene O 6 -methylguanine-DNA methyltransferase (MGMT) may be involved in lymphomagenesis. 21, 22 Its involvement in PEL pathogenesis, however, has not been defined to date.
The role of Epstein-Barr virus (EBV) infection in PEL pathogenesis is not fully elucidated. In fact, EBV infection occurs in 70% of PEL, [1] [2] [3] [4] [5] 20 is typically latent, and is generally monoclonal, [1] [2] [3] [4] [5] 20 suggesting that the virus infects the tumor cells from the early phases of clonal expansion. Because EBV infection in PEL displays a latency I phenotypic profile, ie EBNA1+, EBNA2−, LMP1−, 23, 24 a pathogenetic role of the virus in the development and maintenance of the disease remains to be determined.
Over recent years, a small panel of continuous cell lines has been established from patients with PEL (see Ref. 25 for review). Here, we report the establishment of a novel PEL cell line (called CRO-AP/6), which has been subjected to detailed analysis of morphology, phenotype, karyotype and genotype as well as expression pattern of adhesion molecules. The pattern of cell cycle regulators detected in CRO-AP/6 point to specific abnormalities of cell cycle control in PEL. Whereas the parental PEL sample carries infection by both HHV-8 and EBV, the CRO-AP/6 cell line harbors infection solely by HHV-8. Both CRO-AP/6 and the parental tumor sample harbor biallelic inactivation of MGMT genes by promoter methylation. Overall, the CRO-AP/6 cell line may provide a valuable model for clarifying the pathogenesis and cell cycle control of PEL and it may help understand the relative contribution of HHV-8 and EBV to this disease.
Materials and methods

Patient
The CRO-AP/6 cell line was derived from the pleural effusion of a 26-year-old homosexual man, with a 2-year history of HIV infection, who presented with fever, night sweats, weight loss and diarrhea. Imaging techniques performed at diagnosis and/or at restaging after three courses of CEOP (cyclophosphamide, epirubicin, vincristine, prednisone) showed a nodularity of bowel wall, 3-cm mesenteric lymphadenopathy, mild ascites and a mild right-sided pleural effusion occurring without parenchymal opacities or mediastinal enlargement. The assignment of the case to PEL was based on cytopathologic and immunophenotypic examination of the pleural fluid (Figure 1 ), as well as virologic and molecular genetic analyses (see below) according to previously reported criteria (reviewed in Refs 2 and 4). Microscopic examination of a left colon biopsy revealed small intramucosal foci of non-Hodgkin's lymphoma with anaplastic large cell component infiltrating the lamina propria, but consistently sparing the mucosal epithelium. At diagnosis, CD4 cell count was 84/l and HIV viremia was 52 630 cp/ml. The patient refused further antineoplastic treatments and he was lost to follow-up.
Pathologic samples
Pleural lymphomatous effusion was collected under sterile conditions during diagnostic procedures. After centrifugation, the effusion sediments were used to prepare smears and cell blocks. For morphologic studies, cytospin preparations were routinely fixed and stained by the Papanicolaou method and hematoxylin-eosin. For cell block preparation, cell pellets were Bouin fixed and treated according to a standard regimen used at the Division of Pathology of the Centro di Riferimento Oncologico. The sectioned material from cell blocks was stained with hematoxylin and eosin.
Establishment of cell line and cell culture procedures
Lymphoma cells obtained from pleural effusion were separated by Ficoll-Hypaque (Pharmacia, Uppsala, Sweden) and washed twice in sterile phosphate-buffered saline (PBS). Subsequently, cells were cultured in RPMI 1640 (GIBCO, Paisley, UK) supplemented with 20% heat-inactivated fetal bovine serum (FBS, ICN Biomedicals, Costa Mesa, CA, USA), 2 mM L-glutamine, 100 U/ml penicillin, and 100 g/ml streptomycin (Irvine Scientific, Santa Ana, CA, USA) at 37°C in the presence of 5% CO 2 .
26-28 After 2 weeks the cells started to grow spontaneously. Cultures were fed twice weekly with the above mentioned medium. Once established (the cell line has been grown in permanent uninterrupted culture for more than 1 year), the cell lines were continuously cultured in RPMI 1640-10% FBS at 37°C in the presence of 5% CO 2 .
Immunophenotypic analysis
The immunophenotype of the PEL primary sample and the derived cell line was determined by immunocyto-histochemistry (on cytospins and cell blocks) as previously described. 24, [25] [26] [27] The PEL cell line was also characterized by immunofluorescent flow cytometry, as previously described. 29 Fluorescence was measured in an Epics XL (Coulter, Milan, Italy) flow cytometer. The reagents used in these experiments (along with their sources) are listed in Table 1 .
Cytogenetic analysis
Chromosomal studies were performed on cultured cells by the trypsin-Giemsa banding method. Well-spread metaphases were photographed and arranged according to the recommendation of an International System for human Cytogenetic Nomenclature (ISCN) for cancer cytogenetics. 30 As a first step, conventional cytogenetic analysis was performed; subsequently, to assess doubtful findings, FISH analysis of metaphase spreads was performed using biotinylated DNApainting probes according to the method of Pinkel et al. 31 
DNA extraction and immunogenotypic analysis
Genomic DNA was prepared by cell lysis and proteinase K digestion, followed by 'salting out' extraction and ethanol precipitation. 32 In order to establish the clonality of the CRO-AP/6 PEL cell line, we performed immunoglobulin (Ig) heavy and light chain gene rearrangement analysis by Southern hybridization as previously described. 20 
Detection of viral infection
Analysis of HHV-8 infection was assessed by multiple approaches, including PCR and in situ hybridization (ISH). PCR was performed with primers KS330 233 -F and KS330 233 -R as previously reported. 8 ISH for HHV-8 was assessed by using a 5Ј-end digoxigenin-labeled oligo-probe 33 on formalin-fixed cytospin or cell blocks obtained from the primary sample and the established cell lines. Slides were treated with Proteinase K (Sigma Chemical, St Louis, MO, USA) (1 g/ml for cytospin or 6 g/ml for cell blocks), dehydrated in alcohol, and air dried. Cells or sections were then overlaid with 10-15 l hybridization buffer containing HHV-8 probe (20 g/ml) and denatured at 96°C for 3-6 min and then hybridized overnight at 37°C. After washings at different stringencies (2× SSC at 37°C for 15 min, 1× SSC at 37°C for 15 min, 0.1× SSC at 37°C for 15 min), followed by a final wash in TBS (0.15 M NaCl, 0.1 M Tris pH 7.6, 0.05% Tween 20), hybridization products 
ICC, immunocytochemistry; FC, flow cytometry; s, surface staining; c, cytoplasmic staining; CLA, common leucocyte antigen; −, negative; +, positive Ͻ25%; ++, positive 25-50%; +++, positive 50-75%; ++++, positive Ͼ75%; NT, not tested. were detected by using an anti-DIG polyclonal antibody alkaline phosphatase conjugated (Boehringer, Mannheim, Germany). 5-Bromo-4-chloro-3-indolyl phosphate/nitroblue tetrazolium was used as chromogen. Slides were counterstained with hematoxylin and mounted with an acqueous mounting medium. The specificity of signals was ascertained
Leukemia by abolition of hybridization after pretreatment of sections with DNAse (1 mg/ml for 1 h at 37°C) and by hybridizing HBL-2, an AIDS-Burkitt cell line which does not contain HHV-8. 34 Infection by EBV was investigated by multiple approaches, including ISH and PCR of multiple EBV loci. EBER ISH was performed on formalin-fixed cytospin preparations obtained from the primary sample, from the cultured cells after four passages and from the established cell line, as previously described. 26, 27 Analysis of EBV by PCR was performed as a first step with primers SL-1 and SL-3 representative of the EBV nuclear antigen (EBNA)-1 gene, as previously reported. 8 Subsequently, definition of EBV type-1/type-2 was performed by PCR using primers specific for the EBNA-2 and EBNA-3C genes. 35 Heterogeneity of the LMP-1 gene was investigated by PCR analysis using primers LMP-1/5Ј and LMP-1/3Ј which explore the carboxyterminus of LMP-1 and allow the identification of several LMP-1 variants. 35 Infection by HIV was assessed by PCR analysis using primers derived from a highly conserved DNA sequence of the HIV clone HXB2, as previously reported. 8 
Expression analysis of HHV-8 and EBV antigens
Expression of HHV-8 and EBV latent genes was assessed by analyzing HHV-8 v-cyclin (ORF72) and HHV-8 latent nuclear antigen (LNA/ORF73) along with EBV latent membrane protein 1 (LMP 1) and EBV-encoded nuclear antigen 2 (EBNA 2) in the primary sample and in the derived cell line. The reagents used in these experiments (along with their sources) are listed in Table 2 .
HHV-8 v-cyclin mRNA was determined by using a digoxigenin-labeled probe of 859 bp corresponding to a region of HHV-8 ORF72 kindly provided by Dr P Monini (Laboratory of Virology, Istituto Superiore di Sanità, Rome). ISH was performed as described above. In these experiments, however, only the probe (3 g/ml) was denatured (for 10 min at 96°C) and 5-Bromo-4-chloro phosphate/nitroblue tetrazolium was used as chromogen. For assessment of HHV-8 v-cyclin protein, cytospins were fixed in acetone-chloroform (1:1) solution for 5 min and stored at −80°C until use. Slides were then brought to room temperature (RT), fixed in acetone for 5 min at RT, air dried, fixed in buffered 10% formalin for 10 min at RT, rinsed in PBS pH 7.4, fixed in cold methanol at −20°C for 10 min and then incubated overnight at 4°C with sheep anti-HHV-8 cyclin (Bionostics, Toronto, Canada). After washing, cytospins were incubated with rabbit anti-sheep IgG (Jackson ImmunoResearch Laboratories, West Grove, PA, USA) and then immunostained by using the ABC method 36 (ABC-Elite kit; Vector, Burlingame, CA, USA). LNA/ORF73 was assessed either in acetone-chloroform fixed cytospin preparations or in Immunocyto-histochemistry for LMP 1 and EBNA 2 was performed on cytospin preparations and cell blocks, as previously reported. 24 
Analysis of MGMT inactivation
Analysis of MGMT gene inactivation by promoter methylation was performed by analyzing the DNA methylation patterns in the CpG island of the MGMT gene promoter. This analysis was based on the sodium bisulfite-induced chemical modification of the unmethylated, but not the methylated, cytosines to uracil and subsequent methylation-specific PCR (MSP) using primers specific for either methylated or the modified unmethylated DNA, as previously reported. 21 Briefly, 1 g of DNA was denaturated by NaOH and modified by sodium bisulfite. DNA samples were then purified using Wizard DNA purification resin (Promega, Madison, WI, USA), again treated with NaOH, precipitated with ethanol, and resuspended in water. Sequences of MGMT primers were: 5Ј-TTTGTG-TTTTGATGTTT-GTAGGTTTTTGT-3Ј (upper primer) and 5Ј-AACTCCACACTCTTCCAAAAACAAAACA-3Ј (lower primer) for the unmethylated reaction; 5Ј-TTTCGACGTTCGTAG-GTTTTCGC-3Ј (upper primer) and 5Ј-GCACTCTTCCGA-AAACGAAACG-3Ј (lower primer) for the methylated reaction. The annealing temperature was 59°C. Methylated and unmethylated controls were used in each experiment.
Analysis of genetic lesions
Molecular lesions of BCL-6, c-MYC, BCL-2 and p53 were investigated by a combination of molecular approaches as previously reported. 20 
Results
Establishment of CRO-AP/6 cell line
The PEL cell line CRO-AP/6 has been established from the pleural lymphomatous effusion of an HIV-infected patient. Based on morphologic, immunophenotypic, virologic and genotypic data (see below), the lymphomatous effusion was classified as AIDS-PEL. The cell line has been grown in permanent uninterrupted culture for more than 1 year. Table 3 describes the main characteristics of the CRO-AP/6 cell line according to the guidelines for the characterization and publication of human malignant hematopoietic cell lines. 37 
Clonal analyis
Immunogenotypic studies demonstrated that CRO-AP/6 displays a monoclonal rearrangement of the Ig genes (Table 4) . By testing both Ig heavy and light chain genes with multiple enzymes, an identical pattern of Ig gene rearrangement was observed in the corresponding parental tumor sample (see Figure 2 for representative results) . These data demonstrate the monoclonal B cell origin of this cell line despite the fact that CRO-AP/6 fails to express the most common B cell-associated surface antigens.
Morphologic and immunophenotypic features
Conventional morphologic studies on cytospin preparations and paraffin-embedded sections from cell blocks obtained from the CRO-AP/6 cell line revealed cell pleomorphism and heterogeneity in nuclear size and shape. The spectrum of the morphologic features of CRO-AP/6 included immunoblast-like cells with plasma cell features as well as anaplastic and multilobated or multinucleated large cells (Figure 3 ). CRO-AP/6 and the corresponding parental sample displayed superimposable phenotypic features (Table 1) . Tumor cells exhibited an indeterminate immunophenotype, since they lacked surface Ig and B and T cell-associated antigens. Conversely, CRO-AP/6 and the parental tumor sample expressed leukocyte common antigen (LCA) and various markers associated with activation, including CD30, CD38 and EMA.
CRO-AP/6 was analyzed with a panel of plasma cell-associated markers ( Table 1) . As a first step, the CD138/syndecan-1 (CD138/syn-1) antigen was tested with several antibodies Table 4 Genetic lesions and viral infection in CRO-AP/6 PEL cell line and in the corresponding primary tumour sample Copy number of HHV-8 sequences are reported in brackets.
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Figure 2
Clonal analysis of immunoglobulin heavy-chain (Ig H ) gene configuration of primary effusion lymphoma cell line CRO-AP/6 and the parental tumor sample LFW. Genomic DNA was digested with HindIII and subjected to Southern blot hybridization with a DNA probe representative of the J H locus. U-937, a monoblastic cell line, was used as a control of the germline configuration of Ig H . The cell line CRO-AP/6 and parental tumor sample showed an identical monoclonal rearrangement of Ig H . Only the rearranged band was present in the CRO-AP/6 cell line, whereas the parental tumor sample LFW displayed both the germline band and the rearranged band, consistent with the presence of contaminating cells in the primary specimen.
(B-B4, B-B2, MI15, 1D4) recognizing different epitopes of the CD138/syn-1 molecule. As expected, 38 CRO-AP/6 scored positive with all these anti-CD138/syn-1 MoAbs recognizing different epitopes. Subsequently, CRO-AP/6 was investigated with several MoAbs recognizing plasma cell-associated antigens other than CD138/syn-1 (VS38c, MC186, MI37). CRO-AP/6 scored positive only for the MI37 marker. Therefore, CRO-AP/6 cells expressed most, but not all, of the plasma cell-associated markers tested.
CRO-AP/6 was also tested for selected adhesion molecules known to mediate cell-to-cell and cell-to-ECM interactions (Table 1) . CRO-AP/6 displayed a profile of adhesion molecules characterized by positive expression of ␣4␤1, ␣6␤1, LFA-1, LFA-3, N-CAM, ICAM-1 and H-CAM complexes.
Cytogenetic characteristics
Metaphase spreads were evaluated for chromosome number and structure and 10 karyotypes were prepared (data not shown). The complete karyotype of CRO-AP/6 was 49, XY, der(11) t(4;11) (q26;q25),+?12, ?add(13) (q31ෂ34), del(14) Figure 3 CRO-AP/6 cell line derived from AIDS-related HHV-8-positive primary effusion lymphoma. Tumor cells display pleomorphism and heterogeneity in nuclear shape. A giant cell, resembling the Reed-Sternberg cell of Hodgkin's disease, is also present. Cytospin preparation, hematoxylin-eosin stain. (Original magnification ×400.) (q24), add(16) (q24), +19, i(22)(q10), +mar. These findings were confirmed by FISH analysis (data not shown).
Viral infection
CRO-AP/6 and its parental tumor sample scored positive for HHV-8 infection by both PCR studies and ISH (Tables 2 and  4 and Figure 4) . In both specimens, the approximate copy number of HHV-8 sequences was 20-80 copies of HHV-8 DNA per cell ( Table 4 ). The CRO-AP/6 cell line and the parental sample expressed the HHV-8 LNA/ORF73 antigen ( Table 2) .
By both EBER ISH and PCR analysis, infection by EBV scored positive in the parental sample (Table 4 and Figures 5 
Figure 4
Polymerase chain reaction (PCR) analysis of infection by HHV-8 in primary effusion lymphoma cell line CRO-AP/6 and in the parental tumor sample LFW. Genomic DNA was subjected to PCR amplification using the KS330 233 primers derived from HHV-8 sequences and yelding a 233 base pair amplimer. The PCR reactions were run on to a 2% agarose gel for visualization by ethidium bromide. A negative control, represented by the monoblastic cell line U-937, as well a positive control, represented by the primary effusion lymphoma cell line HBL-6, were included in the experiment. A positive signal was detected in both the CRO-AP/6 cell line and the parental tumor sample LFW. and 6), whereas it scored negative in the fully established CRO-AP/6 cell line (Table 4 and Figures 5 and 6 ). Sequential analysis of EBV infection during CRO-AP/6 establishment was performed by EBER ISH. These experiments demonstrated that, at passage four, EBV infection had become restricted to a fraction (30%) of cells ( Figure 6 ), whereas after full establishment all CRO-AP/6 cells scored negative for EBV infection ( Figure 6 ). Analysis of EBV latent gene expression by immunocytochemistry revealed that both CRO-AP/6 and the corresponding parental tumor sample lacked both LMP-1 and EBNA-2 ( Table 2) .
Infection of the tumor clone by HIV was negative in both CRO-AP/6 and in the corresponding parental tumor sample (not shown).
Expression of viral and cellular regulators of cell cycle
Both CRO-AP/6 and the corresponding parental sample expressed HHV-8 v-cyclin (Table 2 ) and also showed nuclear p27
Kip1 staining of moderate to strong intensity in a large number of tumor cells ( Table 1) . Expression of p27
Kip1 occurred regardless of the high proliferative index of the neoplastic population, as assessed by the proliferation marker Ki-67 (Table 1) .
Analysis of MGMT inactivation
Analysis by MSP of the MGMT gene indicated that methylation of the CpG island in the MGMT promoter occurred in both the CRO-AP/6 cell line and the parental tumor sample (Figure 7) . The observed MGMT methylation of both CRO-AP/6 and the parental tumor sample was assumed to be biallelic, since MSP analysis in both samples failed to produce an amplimer with primers specific for the unmethylated reaction.
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Figure 7
Methylation-specific PCR (MSP) of MGMT genes in CRO-AP/6 and in parental tumor sample LFW. The presence of a visible PCR product in lane M indicates the presence of methylated MGMT genes; the presence of product in lane U indicates the presence of unmethylated genes. PCR reactions were run on to a 2.5% agarose gel for visualization by ethidium bromide. The SW48 cell line was used as positive control for methylated MGMT alleles and peripheral blood mononuclear cells (PBMC) were used as control for umethylated MGMT alleles. Both CRO-AP/6 and the parental tumor sample LFW scored positive for the presence of methylated MGMT genes (83 base pair amplimer) and negative for the presence of unmethylated genes (95 bp amplimer). Because both CRO-AP/6 and the parental tumor sample yielded a MSP product only in lane M, they were assumed to harbor biallelic methylation of MGMT genes.
Genetic lesions of proto-oncogenes and tumor suppressor genes
Molecular studies (summarized in Table 4) showed that the CRO-AP/6 cell line, as well as the parental tumor from which it was derived, were devoid of molecular lesions of c-MYC, BCL-6, BCL-2 and p53.
Discussion
In this report, we have established one novel HHV-8-positive lymphoma cell line, termed CRO-AP/6. The definition of this cell line as AIDS-related PEL, as well as the recognition of its fidelity to the original tumor clone, was based on the results of our multiparameter investigation which included analysis of morphology, immunophenotype and molecular profile of clonality and viral infection. The PEL cell line established in this study may provide a relevant tool to address several issues which concern the pathogenesis of the disease, including abnormalities of cell cycle regulation and the role of EBV infection.
The pattern of cellular and viral cell cycle regulators expressed by CRO-AP/6 point to the existence of cell cycle abnormalities which may represent a peculiar feature of PEL among B cell lymphomas. In fact, both CRO-AP/6 and the parental tumor sample are characterized by a high growth fraction in spite of the expression of the p27
Kip1 cell cycle inhibitor. These data suggest that PEL may be characterized by abrogation of the inverse relationship between p27 Kip1 expression and proliferation which is physiologically encountered in normal lymphoid tissues and is also maintained in B cell NHL, [39] [40] [41] with the exception of a small subset of B cell diffuse large cell lymphomas and Burkitt's lymphoma cases. 39, 42 Notably, co-existence of high growth fraction and p27
Kip1 expression appears to be a selective feature of PEL among the clinico-pathologic spectrum of lymphomatous effusions. 43 The precise mechanism abrogating the inverse relationship between p27
Kip1 expression and proliferation in PEL cells is not known and may be related to the expression of HHV-8 vcyclin by PEL cells. In fact, unlike cellular cyclin D, the v-cyclin activity is resistant to the inhibiting effect of p27 Kip1 . 44 Therefore, it is conceivable that PEL cells express high levels of p27 Kip1 which, however, is unable to inactivate HHV-8 vcyclin and, therefore, is unable to exert its physiologic function of negative regulator of cell cycle progression. Overall, the observations presented in this study prompt further studies aimed at defining the precise relationship between v-cyclin and p27
Kip1 in PEL in vivo. A peculiar feature of CRO-AP/6 is the absence of EBV infection, which conversely occurred in the parental tumor specimen. Sequential analysis of EBV infection suggests that CRO-AP/6 originated from an EBV-negative tumor subclone which, during cell line establishment, was selected over the EBVpositive cell population of the tumor. The reasons why EBVnegative PEL cells may have been selected in vitro are currently unknown. Notably, however, establishment of an EBVnegative PEL cell line from an EBV-positive PEL primary sample has also been observed in the case of the TY-1 cell line. 45 Conceivably, both CRO-AP/6 and TY-1 originated from an EBV-negative subclone of the lymphoma (this study and Ref. 45) . Overall, these observations corroborate the hypothesis that EBV is dispensable for PEL development and growth, as is also suggested by the absence of EBV infection in a fraction of primary PEL samples, particularly among HIV-negative hosts. [1] [2] [3] [4] [5] 20 Biallelic inactivation of the MGMT gene through promoter hypermethylation may represent a novel mechanism involved in PEL pathogenesis. To date, the relevance of epigenetic alterations of MGMT to lymphomagenesis is suggested by the detection of MGMT inactivation in a fraction of aggressive lymphomas and by the observation that MGMT knockout mice develop lymphomas at high frequency. 21, 46 Overall, the detection of MGMT inactivation in CRO-AP/6 and the parental tumor sample prompt investigations aimed at defining the precise frequency of this epigenetic alteration in PEL pathogenesis.
Finally, based on the example of other virus-associated lymphomas, it is generally agreed that PEL pathogenesis requires lesions of cellular loci in addition to viral infection. On this basis, the CRO-AP/6 cell line may represent a valuable tool for the analysis of subtle cytogenetic abnormalities, that may be visualized only by advanced cytogenetic techniques requiring large numbers of growing cells and that may be specifically and/or recurrently associated with PEL. The definition of such cytogenetic abnormalities will represent a major step in the process of understanding the precise molecular pathway leading to PEL.
